Abstract
The NK2 receptor (member of the tachykinin receptor family) is mainly located in the smooth muscle of the urinary, respiratory and gastrointestinal tracts, with limited presence in the CNS. This has raised interest in tachykinin NK2 receptor antagonists for the treatment of urological disorders, asthma. This review outlines progress done after 1998 in the field of NK2 small molecule antagonists, both acting on the NK1 / NK2, NK2 / NK3, NK1 / NK2 / NK3 receptors and selective for the NK2 one.
Keywords: nk2 receptor antagonists
Mini-Reviews in Medicinal Chemistry
Title: Small Molecule Antagonists of the Tachykinin NK2 Receptor [General Reviews]
Volume: 4 Issue: 3
Author(s): Daniela Fattori, Maria Altamura and Carlo Alberto Maggi
Affiliation:
Keywords: nk2 receptor antagonists
Abstract: The NK2 receptor (member of the tachykinin receptor family) is mainly located in the smooth muscle of the urinary, respiratory and gastrointestinal tracts, with limited presence in the CNS. This has raised interest in tachykinin NK2 receptor antagonists for the treatment of urological disorders, asthma. This review outlines progress done after 1998 in the field of NK2 small molecule antagonists, both acting on the NK1 / NK2, NK2 / NK3, NK1 / NK2 / NK3 receptors and selective for the NK2 one.
Export Options
About this article
Cite this article as:
Fattori Daniela, Altamura Maria and Maggi Alberto Carlo, Small Molecule Antagonists of the Tachykinin NK2 Receptor [General Reviews], Mini-Reviews in Medicinal Chemistry 2004; 4 (3) . https://dx.doi.org/10.2174/1389557043487376
DOI https://dx.doi.org/10.2174/1389557043487376 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of
Stem Cells: A Narrative Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema – An Overlooked Adverse Drug Reaction?
Current Diabetes Reviews Targeting Chemoattractant Receptors in Allergic Inflammation
Current Drug Targets - Inflammation & Allergy Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Anti-Inflammatory Trends of 1, 3-Diphenyl-2-propen-1-one Derivatives
Mini-Reviews in Medicinal Chemistry Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer
Current Pharmaceutical Design Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets Toxicities by Herbal Medicines with Emphasis to Traditional Chinese Medicine
Current Drug Metabolism Economic and Cost-Effectiveness Considerations for Pharmacogenetics Tests: An Integral Part of Translational Research and Innovation Uptake in Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Mucoadhesive Chitosan Derivatives as Novel Drug Carriers
Current Pharmaceutical Design Kaempferol-3-<i>O</i>-Rhamnoside Inhibits the Proliferation of Jurkat Cells Through Jun Amino-Terminal Kinase Signaling
The Natural Products Journal Measuring Control: How can Response to Asthma Treatment be Measured?
Current Pediatric Reviews Editorial (Thematic Issue: Immune Modulation)
Current Pharmaceutical Design Allergenic Tropomyosins and Their Cross-Reactivities
Protein & Peptide Letters Personalized Therapies in Pediatric Inflammatory and Autoimmune Diseases
Current Pharmaceutical Design The Potential for Genetically Altered Microglia to Influence Glioma Treatment
CNS & Neurological Disorders - Drug Targets Oseltamivir in Neonates, Infants and Young Children: A Focus on Clinical Pharmacology
Infectious Disorders - Drug Targets Therapeutic Exploitation of Endogenous Anti-Inflammatory Mechanisms:Old and New Leads
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Isoform Selective Phosphoinositide 3-Kinase γ and δ Inhibitors and Their Therapeutic Potential
Recent Patents on Inflammation & Allergy Drug Discovery Role of Radiopharmaceuticals in Development of Inhaled Drugs
Current Pharmaceutical Design